Home > Drug Search >
  • company_query: AFFiRiS
  •   > 
Drug Filter
Category:
chemistry (5) biology (21)
Status:
Approved (5) Phase Ⅲ (4) Phase Ⅱ (10) Phase Ⅰ (7)
Clinical Stage:
Pending (1) Active (15) Discontinued (5)
Bio-Type:
Gene therapy (5) Vaccine (12) Recombinant enzyme (1) Recombinant cytokines (1) Whole antibody (2)
Indication:
Squamous cell cancer (1) Alzheimer's disease (AD) (1) Anemia (1) Angina pectoris (1) Atherosclerosis (3) Coronary artery disease (CAD) (1) Gastric cancer (1) HIV infection (2) Major depressive disorder (MDD) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Peptic ulcer (1) Angioedema (1) Pertussis (1) Prostate cancer (2) Leber congenital amaurosis (1) Tuberculosis (1) Head and neck cancer (1) Dysentery (1) Dermatitis (1) Systemic inflammatory response syndrome (SIRS) (1) Multiple system atrophy (1) Sepsis (1) Mesothelioma (1) Ebola virus disease (EVD) (2) Inflammation (1) Myocardia ischemia (1) Alpha-1 antitrypsin deficiency (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top